Brief: SSY Group Says Nimodipine Obtains Approval For Registration From NMPA Of China
19/03/2025 04:57
March 19 (Reuters) - SSY Group Ltd 2005.HK: NIMODIPINE HAS OBTAINED APPROVAL FOR REGISTRATION FROM NMPA OF CHINA TO BECOME BULK DRUG Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth